Burra Patrizia, Samuel Didier, Sundaram Vinay, Duvoux Christophe, Petrowsky Henrik, Terrault Norah, Jalan Rajiv
Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy.
Centre Hépato-Biliaire, Paris-Saclay University, Inserm research unit 1193, Hôpital Paul Brousse, Villejuif, France.
J Hepatol. 2021 Jul;75 Suppl 1:S178-S190. doi: 10.1016/j.jhep.2021.01.007.
Liver transplantation represents a life-saving treatment for patients with decompensated cirrhosis, a severe condition associated with a high risk of waiting list mortality. When decompensation occurs rapidly in the presence of extrahepatic organ failures, the condition is called acute-on-chronic liver failure, which is associated with an even higher risk of death, though liver transplantation can also markedly improve survival in affected patients. However, there are still gaps in our understanding of how to optimise prioritisation and organ allocation, as well as survival among patients with acute-on-chronic liver failure (both before and after transplant). Moreover, it is urgent to address inequalities in access to liver transplantation in patients with severe alcoholic hepatitis and non-alcoholic steatohepatitis. Several controversies still exist regarding gender and regional disparities, as well as the use of suboptimal donor grafts. In this review, we aim to provide a critical perspective on the role of liver transplantation in patients with decompensated cirrhosis and address areas of ongoing uncertainty.
肝移植是失代偿期肝硬化患者的一种挽救生命的治疗方法,失代偿期肝硬化是一种严重疾病,患者在等待肝移植名单上死亡风险很高。当在存在肝外器官衰竭的情况下迅速发生失代偿时,这种情况称为慢加急性肝衰竭,其死亡风险更高,不过肝移植也可显著提高受影响患者的生存率。然而,我们在如何优化优先排序和器官分配以及慢加急性肝衰竭患者(移植前后)的生存率方面仍存在认识差距。此外,迫切需要解决重症酒精性肝炎和非酒精性脂肪性肝炎患者在肝移植可及性方面的不平等问题。关于性别和地区差异以及使用次优供体移植物仍存在一些争议。在本综述中,我们旨在对肝移植在失代偿期肝硬化患者中的作用提供批判性观点,并探讨仍存在不确定性的领域。